Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 9, Number 7—July 2003

VIM- and IMP-Type Metallo-β-lactamase–Producing Pseudomonas spp. and Acinetobacter spp. in Korean Hospitals

Kyungwon Lee*, Wee Gyo Lee†, Young Uh‡, Gyoung Yim Ha§, Jihyun Cho¶, Yunsop Chong*Comments to Author , and the Korean Nationwide Surveillance of Antimicrobial Resistance group1
Author affiliations: *Yonsei University College of Medicine, Seoul, Korea; †Ajou University School of Medicine, Suwon, Korea; ‡Yonsei University Wonju College of Medicine, Wonju, Korea; §College of Medicine of Dongguk University, Kyongju, Korea; ¶Wonkwang University College of Medicine, Iksan, Korea

Main Article

Table 2

Detection of blaVIM-2 and blaIMP-1 allele from metallo-β-lactamase–producing Pseudomonas spp. and Acinetobacter spp. by polymerase chain reaction

Organism No. isolates (%)
Tested blaVIM-2
positive blaIMP-1 positive
Pseudomonas aeruginosa
42 (100)
0 (0)
P. putida
2 (100)
0 (0)
Acinetobacter spp.
27 (71.1)
11 (28.9)
Total 82 71 (86.6) 11 (13.4)

Main Article

1In addition to the listed authors, this group includes the following: Jung Oak Kang, Moon Yeon Kim, Nam Yong Lee, Mi-Na Kim, Myungshin Kim, Kyung Soon Song, Ki Sook Hong, In Ki Paik, Hye Soo Lee, Sook-Jin Jang, Ae Ja Park, Sung Ha Kang, Won Keun Song, Insoo Rheem, Eui-Chong Kim, Yeon Joon Park, Jong Hee Shin, Myungseo Kang, Young-Kyu Sun, Hee Joo Lee, Hwan-Sub Lim, Jong Wook Lee, and Bo-Moon Shin.

Page created: December 22, 2010
Page updated: December 22, 2010
Page reviewed: December 22, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.